The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[1-[3-[[4-(dimethylamino)but-2-enoyl]amino]phenyl]sulfonyl-4-piperidyl]-4-[(2,4,6-trichlorobenzoyl)amino]-1H-pyrazole-3-carboxamide ID: ALA4580787
Cas Number: 2364489-81-4
PubChem CID: 138454780
Product Number: F288523, Order Now?
Max Phase: Preclinical
Molecular Formula: C28H30Cl3N7O5S
Molecular Weight: 683.02
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cc(Cl)cc3Cl)CC2)c1
Standard InChI: InChI=1S/C28H30Cl3N7O5S/c1-37(2)10-4-7-24(39)33-19-5-3-6-20(15-19)44(42,43)38-11-8-18(9-12-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)13-17(29)14-22(25)31/h3-7,13-16,18H,8-12H2,1-2H3,(H,32,36)(H,33,39)(H,34,41)(H,35,40)/b7-4+
Standard InChI Key: HZPYSAHDRSBARR-QPJJXVBHSA-N
Molfile:
RDKit 2D
44 47 0 0 0 0 0 0 0 0999 V2000
-2.8579 8.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 7.8375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 8.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 6.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 5.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 5.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 5.7750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 4.5375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 4.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 2.0625 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.1105 2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5395 2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 -1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 -1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6674 -2.9599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4125 -3.7445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4125 -3.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6674 -2.9599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4521 -2.7050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0652 -3.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8936 -4.0640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8498 -3.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0213 -2.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4082 -1.6431 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8059 -1.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4190 -2.4922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2036 -2.2373 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2475 -3.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4629 -3.5541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2913 -4.3611 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
15 16 2 0
15 17 2 0
15 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 23 1 0
23 24 2 0
23 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
29 25 1 0
28 29 2 0
29 30 1 0
30 31 1 0
31 32 2 0
31 33 1 0
33 34 2 0
34 35 1 0
34 36 1 0
36 37 2 0
37 38 1 0
37 39 1 0
40 33 1 0
39 40 2 0
40 41 1 0
21 22 1 0
21 42 1 0
43 18 1 0
42 43 1 0
14 15 1 0
44 10 2 0
14 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 683.02Molecular Weight (Monoisotopic): 681.1095AlogP: 4.26#Rotatable Bonds: 10Polar Surface Area: 156.60Molecular Species: BASEHBA: 7HBD: 4#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.75CX Basic pKa: 8.80CX LogP: 3.87CX LogD: 2.54Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.23Np Likeness Score: -1.73
References 1. Sánchez-Martínez C, Lallena MJ, Sanfeliciano SG, de Dios A.. (2019) Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)., 29 (20): [PMID:31477350 ] [10.1016/j.bmcl.2019.126637 ] 2. Xie Z, Hou S, Yang X, Duan Y, Han J, Wang Q, Liao C.. (2022) Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts., 65 (9.0): [PMID:35235745 ] [10.1021/acs.jmedchem.1c02190 ] 3. EUbOPEN. (2023) EUbOPEN Chemogenomics Library - Multiplex, [10.6019/CHEMBL5303300 ] 4. EUbOPEN. (2023) EUbOPEN Chemogenomics Library - IncuCyte, [10.6019/CHEMBL5303304 ] 5. EUbOPEN. (2023) Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library, [10.6019/CHEMBL5308504 ]